Strongbridge Biopharma Plc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Strongbridge Biopharma Plc (SBBP) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Strongbridge Biopharma Plc vs Its Competitors
- TTM: Trailing 12-month revenue of 35M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+15.7% annualized vs trailing 12 months).
- Peer revenue share: Strongbridge Biopharma Plc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
SBBP Sales vs. its Competitors, Q2 2021
Strongbridge Biopharma Plc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Major Pharmaceutical Preparations industry grew revenue 9.1% year over year, combined, vs 29.4% for Strongbridge Biopharma Plc. Strongbridge Biopharma Plc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.